Frederik Cleeren

13PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsMolecular targetsCancer diagnosisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Selective CXCR4-Targeting Radioconjugates Derived from LY2510924: Evaluation of [18F]AlF-NOTA-SC, [177Lu]Lu-BL02, and [161Tb]Tb-BL02 for Theranostic Development.

|Jan 28, 2026
Affinity- and Format-Dependent Pharmacokinetics of 89Zr-Labeled Albumin-Binding VHH Constructs.

Simon Leekens, Peter Casteels, Tom Van Bogaert

|Dec 30, 2025
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges.

Justine Maes, Bernard Pôlet, Janke Kleynhans

|Dec 14, 2025
cGMP-compliant high-yield automated production of [18F]AlF-FAPI-74: optimization of quality control and evaluation of molar dose impact.

Ward Storms, Sofie Celen, Justine Maes

|Nov 27, 2025
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.

Hannes Leupe, Merel Cauwenbergh, Frederik Cleeren

|Mar 11, 2025
Indium-111-Labeled Single-Domain Antibody for In Vivo CXCR4 Imaging Using Single-Photon Emission Computed Tomography.

Muriel Aline Spahn, Stephanie Mareike Anbuhl, Kaat Luyten

Pageof 3

Frequent Collaborators

4 joint publications

Christophe M Deroose

4 joint publications

Guy Bormans

3 joint publications

Janke Kleynhans

3 joint publications

Christopher Cawthorne